Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Schroeder · SciRah

Researcher profile · Semantic Scholar

M. Schroeder

Share profile

M. Schroeder — researcher profile on SciRah

h-index: 51
Works: 272
Citations: 8,779

Most-cited papers

Ruxolitinib for the treatment of steroid-refractory acute GVHD (REACH1): a multicenter, open-label, phase 2 trial.
M. Jagasia, M. Perales, M. Schroeder, H. Ali +9 more
2020Blood268 citations Open access
Semantic Scholar
Genomic and phenotypic characterization of a broad panel of patient derived xenografts reflects the diversity of glioblastoma
R. Vaubel, Shu-Lan Tian, D. Remonde, M. Schroeder +30 more
2019Clinical Cancer Research175 citations Open access
Semantic Scholar
HLA Haploidentical versus Matched Unrelated Donor Transplants with Post-Transplant Cyclophosphamide based prophylaxis.
M. Gooptu, R. Romee, Andrew St. Martin, M. Arora +23 more
2021Blood150 citations Open access
Semantic Scholar
Multidimensional analyses of donor memory-like NK cells reveal new associations with response after adoptive immunotherapy for leukemia
M. Berrien-Elliott, A. Cashen, Celia C. Cubitt, C. Neal +22 more
2020Cancer Discovery118 citations Open access
Semantic Scholar
Hematopoietic cell transplantation donor-derived memory-like NK cells functionally persist after transfer into patients with leukemia
M. Berrien-Elliott, J. Foltz, D. Russler-Germain, C. Neal +36 more
2022Science Translational Medicine105 citations Open access
Semantic Scholar
Systemic IL-15 promotes allogeneic cell rejection in patients treated with natural killer cell adoptive therapy.
M. Berrien-Elliott, M. Becker-Hapak, A. Cashen, Miriam T. Jacobs +19 more
2021Blood99 citations Open access
Semantic Scholar
Distinctive epigenomes characterize glioma stem cells and their response to differentiation cues
Dan-dan Zhou, Bonnie M. Alver, Shuang Li, R. Hlady +7 more
2018Genome Biology91 citations Open access
Semantic Scholar
A Multi-center Phase I Trial of Ipilimumab in Patients with Myelodysplastic Syndromes following Hypomethylating Agent Failure
A. Zeidan, H. Knaus, T. Robinson, A. Towlerton +16 more
2018Clinical Cancer Research88 citations Open access
Semantic Scholar
Motixafortide and G-CSF to mobilize hematopoietic stem cells for autologous transplantation in multiple myeloma: a randomized phase 3 trial
Zachary D. Crees, M. Rettig, R. Jayasinghe, K. Stockerl-Goldstein +28 more
2023Nature Medicine67 citations Open access
Semantic Scholar
Aurora-A kinase oncogenic signaling mediates TGF-β-induced triple-negative breast cancer plasticity and chemoresistance
M. Jalalirad, Tufia C. Haddad, J. Salisbury, D. Radisky +17 more
2021Oncogene60 citations Open access
Semantic Scholar
Selective Vulnerability of Senescent Glioblastoma Cells to BCL-XL Inhibition
Masum Rahman, Ian E Olson, Moustafa A. Mansour, Lucas P. Carlstrom +18 more
2020bioRxiv48 citations Open access
Semantic Scholar
Scavenger receptor CD36 mediates cell-surface antigen transfer to promote thymic regulatory T cell receptor repertoire development and allo-tolerance
Justin S. A. Perry, Emilie V Russler-Germain, You W. Zhou, Whitney E. Purtha +11 more
2018Immunity43 citations Open access
Semantic Scholar
Letermovir discontinuation at D+100 after Allogeneic Stem Cell Transplant is associated with increased CMV-related mortality.
L. Liu, Alicia Yn, Feng Gao, M. Olson +9 more
2022Transplantation and Cellular Therapy41 citations Open access
Semantic Scholar
Efficacy and safety of itacitinib versus placebo in combination with corticosteroids for initial treatment of acute graft-versus-host disease (GRAVITAS-301): a randomised, multicentre, double-blind, phase 3 trial.
R. Zeiser, G. Socié, M. Schroeder, S. Abhyankar +15 more
2022The Lancet Haematology40 citations
Semantic Scholar
Insights into the role of the JAK/STAT signaling pathway in graft-versus-host disease
Ramzi Abboud, Jaebok Choi, P. Ruminski, M. Schroeder +3 more
2020Therapeutic Advances in Hematology39 citations Open access
Semantic Scholar
A Phase I Study of the Combination of Rituximab and Ipilimumab in Patients with Relapsed/Refractory B-Cell Lymphoma
J. Tuscano, E. Maverakis, S. Groshen, D. Tsao-Wei +9 more
2019Clinical Cancer Research37 citations Open access
Semantic Scholar
Machine learning–based scoring models to predict hematopoietic stem cell mobilization in allogeneic donors
Jingyu Xiang, Min Shi, M. Fiala, Feng Gao +7 more
2021Blood Advances27 citations Open access
Semantic Scholar
Ruxolitinib resistance or intolerance in steroid-refractory acute graft-versus-host disease — a real-world outcomes analysis
S. Abedin, Nahida Rashid, M. Schroeder, R. Romee +16 more
2021British Journal of Haematology24 citations Open access
Semantic Scholar
Daratumumab for the treatment of multiple myeloma.
S. Goldsmith, N. Foley, M. Schroeder
2021Drugs of Today21 citations
Semantic Scholar
Next Generation Sequencing-based Validation of the Revised International Staging System for Multiple Myeloma: An Analysis of the MMRF CoMMpass Study.
S. Goldsmith, M. Fiala, James Dukeman, A. Ghobadi +5 more
2019Clinical Lymphoma, Myeloma & Leukemia21 citations
Semantic Scholar
Selinexor combined with cladribine, cytarabine, and filgrastim in relapsed or refractory acute myeloid leukemia
Ramzi Abboud, E. Chendamarai, M. Rettig, K. Trinkaus +10 more
2019Haematologica21 citations Open access
Semantic Scholar
Ruxolitinib in Combination with Corticosteroids for the Treatment of Steroid-Refractory Acute Graft-Vs-Host Disease: Results from the Phase 2 REACH1 Trial
M. Jagasia, H. Ali, M. Schroeder, N. Shah +5 more
2019Biology of Blood and Marrow Transplantation20 citations Open access
Semantic Scholar
A phase 2a randomized clinical trial of intravenous vedolizumab for the treatment of steroid-refractory intestinal acute graft-versus-host disease
Y. Fløisand, M. Schroeder, P. Chevallier, D. Selleslag +10 more
2021Bone Marrow Transplantation19 citations Open access
Semantic Scholar
Combination of dociparstat sodium (DSTAT), a CXCL12/CXCR4 inhibitor, with azacitidine for the treatment of hypomethylating agent refractory AML and MDS
E. Huselton, M. Rettig, Kirsten A. Campbell, A. Cashen +9 more
2021Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis18 citations Open access
Semantic Scholar
The Dynamics of Financial Toxicity in Multiple Myeloma.
M. Fiala, Alice E. Silberstein, M. Schroeder, K. Stockerl-Goldstein +1 more
2023Clinical Lymphoma, Myeloma & Leukemia17 citations Open access
Semantic Scholar
Scavenger receptor CD36 mediates cell-surface antigen transfer to promote thymic regulatory T cell receptor repertoire development and allo-tolerance
Justin S. A. Perry, Emilie V Russler-Germain, You W. Zhou, Whitney E. Purtha +13 more
201816 citations
Semantic Scholar
A Phase I/II Trial of Carfilzomib, Pegylated Liposomal Doxorubicin, and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma
M. Schroeder, M. Fiala, E. Huselton, M. Cardone +7 more
2019Clinical Cancer Research15 citations Open access
Semantic Scholar
DCEP and bendamustine/prednisone as salvage therapy for quad- and penta-refractory multiple myeloma
S. Goldsmith, M. Fiala, Brandon B. Wang, M. Schroeder +4 more
2020Annals of Hematology14 citations
Semantic Scholar
Patient-derived xenografts of central nervous system metastasis reveal expansion of aggressive minor clones.
B. Y. Tew, C. Legendre, M. Schroeder, Tim Triche +17 more
2019Neuro-Oncology13 citations Open access
Semantic Scholar
Safety analysis of patients who received ruxolitinib for steroid-refractory acute or chronic graft-versus-host disease in an expanded access program
M. Schroeder, P. Hari, Amy Blithe, Dilan Paranagama +2 more
2022Bone Marrow Transplantation12 citations
Semantic Scholar
Preclinical modeling in GBM PDX xenografts to guide clinical development of lisavanbulin - a novel tumor checkpoint controller targeting microtubules.
Danielle M. Burgenske, Surabhi Talele, J. Pokorny, A. Mladek +18 more
2021Neuro-Oncology12 citations Open access
Semantic Scholar
Acute Graft-versus-Host Disease: An Update on New Treatment Options
Dilan A. Patel, Mallory Crain, I. Pusic, M. Schroeder
2023Drugs11 citations
Semantic Scholar
In vivo efficacy of tesevatinib in patient-derived xenograft glioblastoma models may be limited by tissue binding and compensatory signaling
S. Kizilbash, Shiv K. Gupta, Karen E. Parrish, Janice K. Laramy +9 more
2021Molecular Cancer Therapeutics11 citations Open access
Semantic Scholar
Maintenance Therapy after Second Autologous Hematopoietic Cell Transplantation for Multiple Myeloma. A CIBMTR Analysis
O. Pasvolsky, M. Yeshurun, Raphael Fraser, Noel Estrada-Merly +26 more
2021Bone Marrow Transplantation11 citations Open access
Semantic Scholar
Glasdegib for the treatment of adult patients with newly diagnosed acute myeloid leukemia or high-grade myelodysplastic syndrome who are elderly or otherwise unfit for standard induction chemotherapy.
S. Goldsmith, A. Lovell, M. Schroeder
2019Drugs of Today11 citations
Semantic Scholar
EZH2 Overexpression in Multiple Myeloma: Prognostic Value, Correlation With Clinical Characteristics, and Possible Mechanisms.
S. Goldsmith, M. Fiala, J. O'Neal, G. Souroullas +3 more
2019Clinical Lymphoma, Myeloma & Leukemia11 citations
Semantic Scholar
Impact of a 40-Gene Targeted Panel Test on Physician Decision Making for Patients With Acute Myeloid Leukemia
Erica K. Barnell, Kenneth F. Newcomer, Zachary L. Skidmore, K. Krysiak +21 more
2021JCO Precision Oncology10 citations Open access
Semantic Scholar
Decitabine salvage for TP53-mutated, relapsed/refractory acute myeloid leukemia after cytotoxic induction therapy
F. Ferraro, Agata Gruszczynska, M. Ruzinova, Christopher A. Miller +16 more
2022Haematologica9 citations Open access
Semantic Scholar
P-225: A first-in-human study of FOR46 in patients with triple refractory Multiple Myeloma
S. Wong, P. Imus, T. Mark, J. Kaufman +10 more
2021Clinical Lymphoma, Myeloma & Leukemia9 citations
Semantic Scholar
SGNBCMA-001: A phase 1 study of SEA-BCMA, a non-fucosylated monoclonal antibody, in subjects with relapsed or refractory multiple myeloma.
Al-Ola A. Abdallah, J. Hoffman, M. Schroeder, C. Jacquemont +4 more
2019Journal of Clinical Oncology9 citations
Semantic Scholar
A Phase I Study of the Safety and Feasibility of Bortezomib in Combination with G-CSF for Stem Cell Mobilization in Patients with Multiple Myeloma
A. Ghobadi, M. Fiala, M. Rettig, M. Schroeder +5 more
2019Clinical Lymphoma, Myeloma & Leukemia9 citations Open access
Semantic Scholar
A Phase I Trial Evaluating the Effects of Plerixafor, G-CSF, and Azacitidine for the Treatment of Myelodysplastic Syndromes
E. Huselton, M. Rettig, T. Fletcher, Julie Ritchey +16 more
2021Leukemia and Lymphoma8 citations Open access
Semantic Scholar
A Pilot Study of CPX-351 (Vyxeos ©) for Transplant Eligible, Higher Risk Patients with Myelodysplastic Syndrome
Meagan A. Jacoby, D. Sallman, B. Scott, Megan M. Haney +9 more
2021Blood8 citations Open access
Semantic Scholar
Phase I Study of Baricitinib Gvhd Prophylaxis in HLA-Matched, Peripheral Blood Allogeneic Hematopoietic Cell Transplant
M. Schroeder, Jaebok Choi, Himachandana Atluri, Jordan J. Atkins +18 more
2022Blood7 citations Open access
Semantic Scholar
SEA-BCMA, an Investigational Nonfucosylated Monoclonal Antibody: Ongoing Results of a Phase 1 Study in Patients with Relapsed/Refractory Multiple Myeloma (SGNBCMA-001)
J. Hoffman, B. Lipe, J. Melear, M. Liedtke +9 more
2021Blood7 citations Open access
Semantic Scholar
A biomarker signature to predict complete response to itacitinib and corticosteroids in acute graft‐versus‐host disease
M. Pratta, S. Paczesny, G. Socié, N. Barkey +5 more
2019British Journal of Haematology7 citations Open access
Semantic Scholar
Updated Study Results of CX-01, an Inhibitor of CXCL12/CXCR4, and Azacitidine for the Treatment of Hypomethylating Agent Refractory AML and MDS
Eric Huselton, A. Cashen, J. Dipersio, Meagan A. Jacoby +5 more
2019Blood7 citations Open access
Semantic Scholar
Prolonged Post-Transplant Ruxolitinib Therapy is Associated with Protection from Severe Gvhd after Allogeneic HCT
Zachariah M. DeFilipp, Haesook T. Kim, Laura W Knight, Devon Kelley +10 more
2022Transplantation and Cellular Therapy6 citations Open access
Semantic Scholar
Mouse models of graft-versus-host disease.
Dilan A. Patel, M. Schroeder, Jaebok Choi, J. Dipersio
2022Methods in Cell Biology6 citations
Semantic Scholar
Despite Use of Upfront Plerixafor and G-CSF, Daratumumab Exposure Reduces Stem Cell Mobilization in Patients with Multiple Myeloma
Jacob S. Edmisson, M. Fiala, Michael J. Slade, Angela M Vickroy +8 more
2022Blood6 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

J. Dipersio×20
Invite
J. Dipersio — researcher profile on SciRah
K. Stockerl-Goldstein×17
Invite
K. Stockerl-Goldstein — researcher profile on SciRah
Geoffrey L. Uy×13
Invite
Geoffrey L. Uy — researcher profile on SciRah
P. Westervelt×13
Invite
P. Westervelt — researcher profile on SciRah

×13

Invite

R. Vij — researcher profile on SciRah

Invite

A. Cashen — researcher profile on SciRah

Invite

C. Abboud — researcher profile on SciRah

Invite

I. Pusic — researcher profile on SciRah

Invite

A. Ghobadi — researcher profile on SciRah

Meagan A. Jacoby×8

Invite

Meagan A. Jacoby — researcher profile on SciRah

Invite

M. Fiala — researcher profile on SciRah

Invite

J. Sarkaria — researcher profile on SciRah